360 High-Risk Vulnerability Immunization Tool V2.0 vs Avast One: Side-by-Side Comparison (2026)

360 High-Risk Vulnerability Immunization Tool V2.0: Tool that immunizes Windows systems against critical vulnerabilities. built by 360 Security Group (Qihoo 360). Core capabilities include Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation..

Avast One: All-in-one security suite with antivirus, VPN, and scam protection. built by Avast. Core capabilities include Antivirus and anti-malware protection, Integrated VPN service, Scam and fraud protection..

Both serve the Endpoint Protection Platform market but differ in approach, feature depth, and target audience.

360 High-Risk Vulnerability Immunization Tool V2.0 differentiates with Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation. Avast One differentiates with Antivirus and anti-malware protection, Integrated VPN service, Scam and fraud protection.

360 High-Risk Vulnerability Immunization Tool V2.0 is developed by 360 Security Group (Qihoo 360). Avast One is developed by Avast. Vendor maturity, funding stage, and team size can be important factors when evaluating long-term viability and support quality.

360 High-Risk Vulnerability Immunization Tool V2.0 and Avast One serve similar Endpoint Protection Platform use cases: both are Endpoint Protection Platform tools, both cover Windows Security. Review the feature comparison above to determine which fits your requirements.